CONFERENCE COVERAGE SERIES
Gladstone Workshop: Tau and Tauopathies: Pathogenic Mechanisms
28 – 30 March 2011
Tauists are having their heyday. First, stakeholders met last March in Las Vegas, Nevada, to discuss therapeutics for the tauopathy frontotemporal dementia. Days later, some 150 researchers flocked to the Gladstone Institute of Neurological Disease, San Francisco, to exchange their latest data at "Tau and Tauopathies: Pathogenic Mechanisms."
The Gladstone Institute teamed up with the German Center for Neurodegenerative Diseases, Bonn, to sponsor this inaugural meeting. Catch the hottest developments in this field with Esther Landhuis's unfolding coverage of the San Francisco conference and her now-complete coverage of the Las Vegas conference. Still hungry for more on tau? Download a copy of Lennart Mucke's in-depth review published in the May 12 issue of Neuron. [Image courtesy of Chris Goodfellow.]
San Francisco: Gladstone Institute Hosts Tau Powwow
In San Francisco, attendees discussed how tau goes awry...
San Francisco: Making Tau Toxic—Post-translational Changes Galore
Given its correlation with Alzheimer’s disease progression, tau hyperphosphorylation has long commanded the field’s attention...
San Francisco: Is Tau Reduction a Good Thing?
Though amyloid-β and tau stand as the pathological hallmarks of AD, only recently have scientists gained insight into how the two could be linked mechanistically...
San Francisco: Tau—Time to Shine as Therapeutic Target?
Attendees bonded over a common research interest—the protein tau and its role in neurodegeneration...